Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter

Molecular Biology Reports

Volumn 34, Issue 4, 2007, Pages 225-231

  Thirunavukkarasu, Kannan ^a   Pei, Yong ^a   Wei, Tao ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

ADAMTS 5 aggrecanase 2; Promoter; Reporter gene assay; Runx2; Transfection

Indexed keywords

ADAMTS 5 PROTEIN; AGGRECANASE; AGGRECANASE 2; METALLOPROTEINASE; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL MATURATION; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME DEGRADATION; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERTROPHY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; TRANSCRIPTION REGULATION;

ADAM PROTEINS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CLONING, MOLECULAR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

BOVINAE; MUS;

EID: 35148831210     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-006-9037-3     Document Type: Article

References (26)

1. Pratta MA, Yao W, Decicco C, Tortorella MD, Liu R-Q, Copeland RA, Magolda R, Newton RC, Trzaskos JM, Arner EC (2003) Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem 278:45539-45545
2. Arner EC, Pratta MA, Decicco CP, Xue CB, Newton RC, Trzaskos JM, Magolda RL, Tortorella MD (1999) Aggrecanase. A target for the design of inhibitors of cartilage degradation. Ann New York Acad Sci 878:92-107
3. Lohmander LS, Neame PJ, Sandy JD (1993) The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arth Rheum 36:1214-1222
4. Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, Burn T, Arner E (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 275:18566-18573
5. Sandy JD, Thompson V, Doege K, Verscharen C (2000) The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1. Biochem J 351:161-166
6. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, Wynn R, Duke JL, George HJ, Hillman MC Jr, Murphy K, Wiswall BH, Copeland RA, Decicco CP, Bruckner R, Nagase H, Itoh Y, Newton RC, Magolda RL, Trzaskos JM, Burn TC (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274:23443-23450
7. Stanton H, Rogerson F, East C, Golub S, Lawlor K, Meeker C, Little C, Last K, Farmer P, Campbell I, Fourie A, Fosang A (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648-652
8. Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD (2002) Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277:22201-22208
9. Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, Flannery CR, Kanki K, Wang E, Peluso D, Yang Z, Majumdar MK, Morris E (2004) Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arth Rheum 50:2547-2558
10. Glasson S, Askew R, Sheppard B, Carito B, Blanchet T, Ma H, Flannery C, Peluso D, Kanki K, Yang Z, Majumdar M, Morris E (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644-648
11. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754
12. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T (1999) Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dynam 214:279-290
13. Takeda S, Bonnamy J-P, Owen MJ, Ducy P, Karsenty G (2001) Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 15:467-481
14. Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto H, Nakata K, Takada K, Kurisu K, Komori T (2001) Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Bio 153:87-99
15. Zhang MQ (2006) Identification of human gene core promoters in silico. Genome Res 8:319-326
16. Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi JY, Terry A, Hu M, Jones S, Neil JC, Lian JB, Stein JL, Van Wijnen AJ, Stein GS (2000) Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol 184:341-350
17. Craig AM, Denhardt DT (1991) The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 100:163-171
18. Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH (2004) Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr Cartilage 12:963-973
19. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S (1998) Transcriptional regulation of osteopontin gene in vivo by PEBP2aA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525
20. Jimenez MJG, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C (1999) Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442
21. Ducy P, Karsenty G (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869
22. Selvamurugan N, Chou WY, Pearman AT, Pulumati MR, Partridge NC (1998) Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273:10647-10657
23. Farr A, Roman A (1992) A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res 20:920
24. Geoffroy V, Ducy P, Karsenty G (1995) A PEBP2a/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270:30973-30979
25. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD (1994) PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 14:5558-5568
26. Thirunavukkarasu K, Pei Y, Moore TL, Wang H, Yu X-P, Geiser AG, Chandrasekhar S (2006) Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. Biochem Biophys Res Comm 345:197-204